UY30522A1 - Combinaciones antitumorales que contienen derivados de taxano - Google Patents

Combinaciones antitumorales que contienen derivados de taxano

Info

Publication number
UY30522A1
UY30522A1 UY30522A UY30522A UY30522A1 UY 30522 A1 UY30522 A1 UY 30522A1 UY 30522 A UY30522 A UY 30522A UY 30522 A UY30522 A UY 30522A UY 30522 A1 UY30522 A1 UY 30522A1
Authority
UY
Uruguay
Prior art keywords
taxano
antitumoral
containing derivatives
combinations containing
derivatives
Prior art date
Application number
UY30522A
Other languages
English (en)
Inventor
Patricia Vrignaud
Fromond Claudia
Marie-Christine Bissery
Original Assignee
Sanofi Aventis
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=37596199&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=UY30522(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Sanofi Aventis filed Critical Sanofi Aventis
Publication of UY30522A1 publication Critical patent/UY30522A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/337—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having four-membered rings, e.g. taxol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/395—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum
    • A61K39/39533—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals
    • A61K39/39558—Antibodies; Immunoglobulins; Immune serum, e.g. antilymphocytic serum against materials from animals against tumor tissues, cells, antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Epoxy Compounds (AREA)

Abstract

Se describe una composicion farmacéutica compuesta por acetociclopropil taxotere o uno de sus derivados, y al menos un agente de alquilacion, un antimetabolito, un veneno del husillo, una epidofilotoxina, un antibiotico, una enzima, un inhibidor de topoisomerasa, un complejo de coordinacion de platino, un modificador de la respuesta biologica o un inhibidor del factor de crecimiento.
UY30522A 2006-08-03 2007-08-03 Combinaciones antitumorales que contienen derivados de taxano UY30522A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP06291264A EP1913958B1 (en) 2006-08-03 2006-08-03 Antitumor compositions containing acetylcyclopropyl docetaxel and trastuzumab

Publications (1)

Publication Number Publication Date
UY30522A1 true UY30522A1 (es) 2008-02-29

Family

ID=37596199

Family Applications (1)

Application Number Title Priority Date Filing Date
UY30522A UY30522A1 (es) 2006-08-03 2007-08-03 Combinaciones antitumorales que contienen derivados de taxano

Country Status (19)

Country Link
US (1) US20090196869A1 (es)
EP (2) EP1913958B1 (es)
JP (1) JP2009545580A (es)
KR (1) KR20090037444A (es)
CN (1) CN101495144A (es)
AR (1) AR062164A1 (es)
AT (1) ATE553777T1 (es)
AU (1) AU2007280099A1 (es)
BR (1) BRPI0715082A2 (es)
CA (1) CA2656887A1 (es)
CL (1) CL2007002257A1 (es)
GB (1) GB2440643B (es)
IL (1) IL195770A0 (es)
MX (1) MX2009000856A (es)
PE (1) PE20080282A1 (es)
RU (1) RU2414930C2 (es)
TW (1) TW200820964A (es)
UY (1) UY30522A1 (es)
WO (1) WO2008015578A2 (es)

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4753894A (en) 1984-02-08 1988-06-28 Cetus Corporation Monoclonal anti-human breast cancer antibodies
JP3208517B2 (ja) * 1992-07-01 2001-09-17 ブリストル−マイヤーズ スクイブ カンパニー ７，８−シクロプロパタキサン類
NZ248017A (en) * 1992-07-01 1994-12-22 Bristol Myers Squibb Co 7-fluoro-taxol derivatives, precursors and pharmaceutical compositions thereof
US6441026B1 (en) * 1993-11-08 2002-08-27 Aventis Pharma S.A. Antitumor compositions containing taxane derivatives
US6333348B1 (en) * 1999-04-09 2001-12-25 Aventis Pharma S.A. Use of docetaxel for treating cancers
US7041292B1 (en) * 1999-06-25 2006-05-09 Genentech, Inc. Treating prostate cancer with anti-ErbB2 antibodies
JP4579471B2 (ja) * 1999-06-25 2010-11-10 ジェネンテック， インコーポレイテッド 抗ＥｒｂＢ２抗体を用いる前立腺癌の処置
NZ517150A (en) * 1999-08-27 2005-01-28 Genentech Inc Dosages for treatment with anti-ErbB2 antibodies
US7361343B2 (en) * 2003-01-21 2008-04-22 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of CD63
US7393531B2 (en) * 2003-01-21 2008-07-01 Arius Research Inc. Cytotoxicity mediation of cells evidencing surface expression of MCSP
JP2006316040A (ja) * 2005-05-13 2006-11-24 Genentech Inc Ｈｅｒｃｅｐｔｉｎ（登録商標）補助療法

Also Published As

Publication number Publication date
ATE553777T1 (de) 2012-05-15
MX2009000856A (es) 2009-02-04
JP2009545580A (ja) 2009-12-24
EP2049155A2 (en) 2009-04-22
KR20090037444A (ko) 2009-04-15
EP2049155B1 (en) 2012-04-18
CA2656887A1 (en) 2008-02-07
EP1913958B1 (en) 2009-12-23
GB0714517D0 (en) 2007-09-05
WO2008015578A3 (en) 2008-04-10
EP1913958A1 (en) 2008-04-23
AU2007280099A1 (en) 2008-02-07
CL2007002257A1 (es) 2008-04-18
IL195770A0 (en) 2009-09-01
CN101495144A (zh) 2009-07-29
RU2414930C2 (ru) 2011-03-27
GB2440643B (en) 2011-04-06
WO2008015578A2 (en) 2008-02-07
BRPI0715082A2 (pt) 2014-11-11
PE20080282A1 (es) 2008-04-24
AR062164A1 (es) 2008-10-22
RU2009107525A (ru) 2010-09-10
GB2440643A (en) 2008-02-06
US20090196869A1 (en) 2009-08-06
TW200820964A (en) 2008-05-16

Similar Documents

Publication Publication Date Title
CL2008003405A1 (es) Compuestos derivados de tienopiridina, inhibidores de la enzima integrasa del vih; composicion farmaceutica que comprende a dichos compuestos; y su uso para tratar una infeccion por vih.
DK1753440T3 (da) Oral administrationsform indeholdende probiotiske bakterier
CY1120961T1 (el) Δοσολογικες μορφες απο του στοματος που περιλαμβανουν αντιαιμοπεταλιακο παραγοντα και αναστολεα οξεος
ATE493037T1 (de) Mykotoxin reduzierende zusammensetzung
CL2008003653A1 (es) Uso de un inhibidor de sglt derivado de glucopiranosilo y un inhibidor de dppiv seleccionado para tratar la diabetes; y composicion farmaceutica.
AR045667A1 (es) Solvato acetonico del dimetoxi docetaxel y su procedimiento de preparacion
MX2009004778A (es) Enzima para la produccion de peracido de cadena larga.
DOP2013000016A (es) Formas cristalinas del dimetoxi-docetaxel y sus procedimientos de preparacion
CL2008001381A1 (es) Compuestos derivados de tripeptidos que contienen heterociclos nitrogenados; composicion farmaceutica que comprende a dichos compuestos; y uso para tratar una infeccion de hepatitis c o vih.
BR112012015721A2 (pt) modificação covalente de proteínas dirigida por ligante
CO6210786A2 (es) Implemento de cuidado oral que alberga un agente de cuidado oral
CL2008001740A1 (es) Compuestos derivados de piperidinas sustituidas, inhibidores de la dna-girasa y/o topoisomerasa iv; procedimeinto para su preparacion; composiicon farmaceutica que comprende estos compustos y su uso en el tratamiento de una infeccion bacteriana.
ATE432711T1 (de) Arginindeiminase enthaltende erythrozyten
MEP8509A (en) Combination treatment for diabetes mellitus
GT201000037A (es) Depsipéptidos cíclicos
NO20091509L (no) Substituerte tetrahydropyrrolopyrazinforbindelser med affinitet KCNQ2/3 K+ kanal og anvendelse derav i medikamenter
CR11363A (es) Composicion de zibotentan que contiene manitol y/ o celulosa microcristalina
BR112012014925A2 (pt) compostos promotores de replicação de células beta e métodos de uso dos mesmos
ECSP056011A (es) Derivados azabiciclicos de piridiloximetilo y bencisoxazol
AR077049A1 (es) Aptamero contra quimasa y su uso
RS51896B (en) The use of glucose isomerase in the treatment of fructose intolerance
CL2007001910A1 (es) Compuestos derivados de penem; composicion farmaceutica; y uso en el tratamiento de una infeccion bacteriana.
BRPI0515161A (pt) substratos enzimáticos derivados de fenoxazinona e seu uso como revelador na detecção de microorganismos com atividade de peptidase
UY30522A1 (es) Combinaciones antitumorales que contienen derivados de taxano
CR11613A (es) Asociacion entre una sal de bis-tiazolio o uno de sus precursores y artemisinina o uno de sus derivados para el tratamiento del paludismo grave

Legal Events

Date Code Title Description
109 Application deemed to be withdrawn

Effective date: 20140715